Tumor Antigens Help Explain Varied Reactions to Immunotherapy (2 of 5) (IMAGE)
Caption
Even complex regions of evolved tumors bear hallmarks of their origins, shown here in yellow. This material relates to a paper that appeared in the March 3, 2016, online issue of Science, published by AAAS. The paper, by N. McGranahan at The Francis Crick Institute in London, UK, and colleagues was titled, 'Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.'
Credit
Cancer Research UK, produced by Phospho Biomedical Animation
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content